Andrew T. Ralya
Affiliations: | University of Kansas Medical Center, Kansas City, KS, United States |
Area:
pain neurobiologyGoogle:
"Andrew Ralya"Mean distance: 17.56 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Kenneth E. McCarson | grad student | 2004-2011 | University of Kansas | |
| (Sex steroids modulate nociception, and estrogen modifies supraspinal nociceptive activation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Leary SES, Park JR, Reid JM, et al. (2017) Pediatric phase 1 trial and pharmacokinetic study of trebananib in relapsed solid tumors ADVL1115: A Children's Oncology Group phase 1 consortium report. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Norris RE, Fox E, Reid JM, et al. (2015) Phase I trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A Children’s Oncology Group Study. Journal of Clinical Oncology. 33: 10036-10036 |
| Ralya A, McCarson KE. (2014) Acute estrogen surge enhances inflammatory nociception without altering spinal Fos expression. Neuroscience Letters. 575: 91-5 |
| Leary S, Park JR, Reid JM, et al. (2013) A phase I trial and pharmacokinetic study of trebananib (AMG386) in children with recurrent or refractory solid tumors: A Children’s Oncology Group Phase 1 Consortium report. Journal of Clinical Oncology. 31: 2538-2538 |
| McCarson KE, Ralya A, Reisman SA, et al. (2005) Amitriptyline prevents thermal hyperalgesia and modifications in rat spinal cord GABA(B) receptor expression and function in an animal model of neuropathic pain. Biochemical Pharmacology. 71: 196-202 |